$30.110
+0.039 (+0.13%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
¿Debería comprar acciones de Korsana Biosciences, Inc.?
Korsana Biosciences (KRSA) appears to be a good buy right now due to its recent analyst upgrades and strong potential in the Alzheimer's treatment market. The stock is currently priced at $31.31, significantly below the analyst price targets of $70 and $44, indicating substantial upside potential. Furthermore, the gross margin stands at 100% for the upcoming quarters, reflecting the company's strong profitability potential once it begins generating revenue. However, the main risk is the projected net income loss of $3,177,000 in Q1 2026, which highlights ongoing financial challenges.
KRSA cerró en $30.11 el Wednesday, tras subir +0.13%
Korsana Biosciences, Inc. (KRSA) last closed at $30.2199993, gaining +0.37%. These facts feed the 1-day and 1-week KRSA price prediction above.
Factores de la previsión
Los factores de la previsión de Korsana Biosciences, Inc. (KRSA) combinan patrones gráficos similares, estacionalidad y medias móviles.
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Análisis de estacionalidad de KRSA
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.